Inhibrx Biosciences (INBX) Current Assets: 2023-2025
Historic Current Assets for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $161.4 million.
- Inhibrx Biosciences' Current Assets fell 22.19% to $161.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.4 million, marking a year-over-year decrease of 22.19%. This contributed to the annual value of $160.4 million for FY2024, which is 45.69% down from last year.
- As of Q3 2025, Inhibrx Biosciences' Current Assets stood at $161.4 million, which was down 16.78% from $194.0 million recorded in Q2 2025.
- Inhibrx Biosciences' Current Assets' 5-year high stood at $295.4 million during Q4 2023, with a 5-year trough of $160.4 million in Q4 2024.
- Over the past 3 years, Inhibrx Biosciences' median Current Assets value was $207.4 million (recorded in 2024), while the average stood at $212.0 million.
- Data for Inhibrx Biosciences' Current Assets shows a maximum YoY crashed of 45.69% (in 2024) over the last 5 years.
- Inhibrx Biosciences' Current Assets (Quarterly) stood at $295.4 million in 2023, then slumped by 45.69% to $160.4 million in 2024, then decreased by 22.19% to $161.4 million in 2025.
- Its last three reported values are $161.4 million in Q3 2025, $194.0 million for Q2 2025, and $223.4 million during Q1 2025.